Asuransi Mandiri Secure CritiCare

Asuransi Mandiri Secure CritiCare is a deliberate counter-bet to the industry’s arms race on condition counts. While most Indonesian CI products compete by covering 30, 60, or 77 conditions, AXA Mandiri has built a product that covers exactly four — stroke, cancer, cardiovascular/heart disease, and kidney failure — but covers each of them across three stages (early, intermediate/final, and terminal) with structured payouts at every step. The structural distinctiveness is not the breadth but the depth: a customer diagnosed with early-stage cancer receives 50% of their sum assured in cash, continues holding their policy, and when the disease progresses to final stage receives the remaining 50% — all while a guaranteed cash stream (Plan 5/10) keeps paying out regardless of CI claims, and a full return of multiples of premiums waits at policy maturity. The death benefit escalates 3% per year (capped by entry age), meaning the life protection does not erode quietly against Indonesian inflation. Combined with a maximum total life payout of 250% SA (death + accident + public transport accident), this product stacks multiple benefit layers on a narrow but clinically relevant CI footprint — the four conditions it covers account for the overwhelming majority of CI claims in Indonesia by incidence and severity. For Legacy Income agents, this is a competitor product to understand well: it will come up in client conversations, particularly among customers already banking with Bank Mandiri who were pitched by AXA Mandiri’s Financial Advisors in-branch.

---

The official illustration uses Bapak Adi, 40-year-old male, Plan 5, Rp 1 billion SA, 5-year payment term, 10-year coverage, semi-annual premium Rp 83.332.500 (Rp 166.665.000/year).

Critical insight for agents: The guaranteed cash stream and maturity benefit are paid regardless of CI claims — they are structural not conditional. A customer who claims early-stage cancer in year 3 still receives Rp 16.6M/year from years 6–9 and the Rp 833M maturity benefit if alive at year 10. This “heads I win, tails I also win” framing is the strongest retention narrative for Plan 5 and Plan 10. For Plan 1 (single premium Rp 1B+), the endowment structure delivers 106% return at year 10 — modest, but combined with CI and death protection on a lump-sum deployment, it targets a different segment: high liquidity, low premium-commitment tolerance.

---

Sweet Spot — Lead with Secure CritiCare

• Age 30–50, employed or business owner, has some medical/hospitalization cover already (Mandiri bank customer or not)
• Household income Rp 15M–50M/month — Plan 5 at Rp 166M/year (Rp 14M/month) sits at the upper-middle of this band; Plan 10 at Rp 12M/year (Rp 1M/month) enters the aspirational middle market
• Has family history of stroke, cancer, heart disease, or kidney disease — the 4-condition focus resonates specifically when the customer has personal relevance
• Wants guaranteed savings alongside protection — the guaranteed cash value and maturity return are the endowment hook; prospects who resist pure protection but respond to “you get your money back” are natural fits
• Risk-averse savers who have bank deposits but have not bought insurance — the bancassurance positioning (Mandiri branch FAs) targets this segment heavily; Legacy Income agents will encounter these customers when they ask why they should consider Allianz instead
• Plan 1 specific: customers with Rp 1B+ liquid capital seeking a structured, insured deployment with guaranteed 106% return in 10 years plus CI/death cover — competes with time deposits

Borderline Fit — Discuss but Qualify Carefully

• Age 51–60 (Plan 5 only; Plan 10 closes at age 55 for insured) — premium load increases materially; 10-year coverage term may feel short for some customers
• Prospects who already have comprehensive CI coverage with 50+ conditions — Secure CritiCare’s 4-condition scope may feel like a step down, even if the early+mid+final staging offers deeper per-condition coverage
• Customers who want long-term coverage — this product ends at 10 years (Plan 1/5) or 15 years (Plan 10), not to age 70/99/100; if the customer wants lifetime protection, this is the wrong product
• Customers focused primarily on premium cost efficiency — the premium-to-SA ratio is higher than term CI riders; the guaranteed cash value is the economic justification

Do Not Pitch

• Customers wanting broad CI coverage across many conditions — if a customer says “I want to be covered for as many diseases as possible,” this is the wrong product; Allianz Flexi CI (77 conditions) wins on breadth
• Customers needing long-term or lifetime protection — the 10/15-year coverage horizon and age-70 cap mean no one should frame this as a permanent solution
• Mass market customers with monthly disposable below Rp 3M — Plan 10 minimum Rp 12M/year (Rp 1M/month) is accessible but requires consistent cash flow; lapse risk is high if income is volatile
• Customers whose primary concern is hospital room costs and outpatient care — this is a CI + endowment product, not a medical card; hospital expenses are not covered; medical card must come first
• Prospects where the AXA Mandiri bancassurance channel is the incumbent and Legacy Income is trying to win the relationship — compete on Allianz’s strengths (breadth, lifetime cover), not on this product’s terms

---

---

Qualitative benchmarking only — CI category structurally heterogeneous. No quantitative population benchmarks meet the 60% category-coverage threshold. Comparisons below are drawn from available product briefs: Allianz Flexi CI (77 conditions), Allianz LegacyPro (CI waiver rider), TMLI CI Guard and Critical Guard.

---

Opening Frame — The 4-Condition Focus

“Most people who end up in an ICU or fighting for their life are dealing with one of four things: a stroke, cancer, a heart attack, or kidney failure. Secure CritiCare doesn’t try to cover every condition in the medical dictionary. It focuses deeply on those four — and it pays you at the early stage, the serious stage, and if the doctors say it’s terminal. That’s three potential payouts from one policy.”

“Sebagian besar orang yang benar-benar dalam kondisi kritis biasanya terkena empat hal: stroke, kanker, serangan jantung, atau gagal ginjal. Secure CritiCare bukan produk yang coba cover semua penyakit. Fokusnya tepat di empat penyakit itu — dan bayarnya bisa tiga kali: waktu stadium awal, waktu stadium serius, dan kalau dokter sudah bilang kondisinya terminal. Tiga kemungkinan klaim dari satu polis.”

—

Structural Value Prop — Not a Hospital Plan

“This is not a hospital insurance plan. It doesn’t pay for room charges or medical bills. What it does is give you a large cash lump sum — up to 100% of your sum assured — when you’re diagnosed with a serious critical illness. That money is yours to use however you need: covering treatment costs, replacing lost income, paying off a mortgage, or supporting your family while you’re unable to work. It’s financial flexibility at the moment you need it most.”

“Ini bukan asuransi rumah sakit. Bukan yang bayarin tagihan rawat inap atau obat-obatan. Yang dikasih adalah uang tunai dalam jumlah besar — bisa sampai 100% dari Uang Pertanggungan — begitu terdiagnosa penyakit kritis yang serius. Uangnya bebas mau dipakai untuk apa: bayar biaya pengobatan, nutup penghasilan yang hilang, bayar cicilan rumah, atau jaga keluarga waktu kita nggak bisa kerja. Fleksibilitas finansial di momen yang paling dibutuhkan.”

—

The Close — Heads I Win, Tails I Also Win

“Here’s what I want you to see clearly. If you get seriously ill and make a claim — you receive the CI benefit in cash. If nothing happens and you stay healthy to the end of the policy — you receive the maturity payout. And during the policy, you’re getting guaranteed cash payments every year from year 6 onward regardless of whether you’ve made any claim. You’re not betting on getting sick. You’re building a structure where something positive comes back to you either way.”

“Ini yang perlu dilihat dengan jelas. Kalau kamu sakit kritis dan klaim — dapat uang tunai dari manfaat penyakit kritis. Kalau kamu sehat sampai akhir masa polis — dapat Manfaat Akhir Masa Asuransi. Dan selama masa polis berjalan, ada Manfaat Tunai Dijamin yang dibayarkan setiap tahun mulai tahun ke-6, mau ada klaim atau nggak. Kamu nggak sedang bertaruh sama penyakit. Kamu membangun struktur di mana hasilnya positif ke dua arah.”

—

The Guaranteed Cash Pitch

“One thing that makes Plan 5 and Plan 10 different from a pure CI product is the guaranteed cash payment. Starting from policy year 6 — or year 11 for Plan 10 — AXA Mandiri pays you a guaranteed cash amount every year, for four consecutive years, automatically. No claim needed. The insured just has to be alive and the policy active. For Plan 5, that’s 10% of your annual premium — about Rp 16.7 million per year if you’re paying Rp 167 million annually. Think of it as a built-in cash return during the back half of the policy.”

“Salah satu hal yang bikin Plan 5 dan Plan 10 beda dari produk CI biasa adalah Manfaat Tunai Dijamin. Mulai tahun polis ke-6 — atau tahun ke-11 untuk Plan 10 — AXA Mandiri langsung transfer uang tunai ke kamu setiap tahun, empat tahun berturut-turut, otomatis. Nggak perlu klaim apapun. Tertanggung cukup masih hidup dan polis aktif. Untuk Plan 5, nilainya 10% dari premi tahunan — sekitar Rp 16,7 juta per tahun kalau premi tahunan kamu Rp 167 juta. Bayangkan ini sebagai pengembalian kas bawaan di paruh kedua masa polis.”

—

Objection 1: “Only 4 conditions is too narrow — what if I get something else?”

Don't say “Four is actually enough” or “most people only get these four anyway”

Do say “That’s a fair point to raise. The four conditions — stroke, cancer, heart disease, and kidney failure — account for the majority of critical illness claims by incidence in Indonesia, which is why AXA Mandiri chose to build deep coverage around them specifically. But you’re right that life doesn’t guarantee it will be one of those four. If you want coverage across a much wider range of conditions, a product like Allianz Flexi CI covers 77 conditions at early and major stages. The question is whether you want depth on the most likely four, or breadth across many — and that’s a real strategic choice between these two products.”

Jangan bilang “Empat itu sudah cukup kok” atau “kebanyakan orang memang kena empat itu”

Sebaiknya bilang “Itu pertanyaan yang wajar. Empat penyakit ini — stroke, kanker, penyakit jantung, dan gagal ginjal — menyumbang sebagian besar klaim penyakit kritis di Indonesia. Makanya AXA Mandiri pilih bangun perlindungan yang dalam khusus untuk keempat ini. Tapi kamu benar, hidup nggak bisa dijamin hanya kena salah satu dari empat itu. Kalau kamu mau coverage yang jauh lebih luas, produk seperti Allianz Flexi CI cover 77 kondisi di stadium awal dan stadium mayor. Pertanyaannya: kamu mau yang dalam di empat yang paling mungkin, atau yang luas di banyak kondisi? Itu pilihan strategi yang nyata antara dua produk ini.”

—

Objection 2: “Allianz covers 77 conditions — why would I choose only 4?”

Don't say “Allianz is not as good” or “77 conditions is just marketing”

Do say “Allianz Flexi CI is a strong product — 77 conditions is genuinely meaningful coverage, and the early stage definitions are broad. The honest difference is this: Secure CritiCare is structured as a combination endowment and CI product, so part of your premium is going toward guaranteed savings and the maturity return. Allianz Flexi CI is a pure protection play. If you want maximum CI breadth at the lowest protection premium, Allianz is the right answer. If you want CI built into an endowment wrapper where you’re guaranteed to get something back at the end, Secure CritiCare is structured for that. They’re not directly comparable because they’re solving different problems.”

Jangan bilang “Allianz nggak sebagus itu” atau “77 kondisi itu cuma marketing”

Sebaiknya bilang “Allianz Flexi CI itu produk yang kuat — 77 kondisi itu coverage yang memang bermakna, dan definisi stadium awalnya luas. Bedanya yang jujur begini: Secure CritiCare itu produk kombinasi antara tabungan bergaransi dan CI, jadi sebagian premi kamu masuk ke komponen tabungan dan pengembalian di akhir masa polis. Allianz Flexi CI itu murni proteksi. Kalau kamu mau jangkauan CI seluas mungkin dengan premi proteksi paling efisien, Allianz adalah jawabannya. Kalau kamu mau CI yang sudah termasuk dalam struktur tabungan bergaransi dan ada sesuatu yang pasti kamu dapat di akhir, Secure CritiCare yang cocok. Keduanya nggak bisa dibandingkan langsung karena memecahkan masalah yang berbeda.”

—

Objection 3: “The premium is too expensive”

Don't say “It’s actually affordable if you think about it” or “you can’t put a price on health”

Do say “Let’s look at what you’re paying for. At Rp 24 million per year for Plan 5, over five years you pay in Rp 120 million — actually Rp 166 million for the Rp 1 billion SA illustrated. But that Rp 166 million per year is buying you: a Rp 1 billion CI benefit if you’re diagnosed with a critical illness, up to Rp 2.5 billion in death benefit if an accident is involved, guaranteed cash payments from year 6 to 9, and a near full return of total premiums at maturity. If the premium feels high, we can look at Plan 10 which starts at Rp 12 million per year, or we can size the sum assured down to match a comfortable premium. What monthly budget were you thinking of?”

Jangan bilang “Sebetulnya terjangkau kok kalau dipikir lagi” atau “kesehatan nggak bisa dinilai dengan uang”

Sebaiknya bilang “Mari kita lihat apa yang kamu bayar. Plan 5 dengan SA Rp 1 miliar, premi tahunan sekitar Rp 167 juta selama 5 tahun. Tapi Rp 167 juta per tahun itu beli: manfaat CI Rp 1 miliar kalau kena penyakit kritis, manfaat meninggal dunia sampai Rp 2,5 miliar kalau kecelakaan, Manfaat Tunai Dijamin dari tahun ke-6 sampai ke-9, dan hampir seluruh premi yang sudah dibayar kembali di akhir masa polis. Kalau preminya terasa berat, kita bisa lihat Plan 10 yang mulai dari Rp 12 juta per tahun, atau kita sesuaikan Uang Pertanggungannya ke angka yang lebih nyaman. Kira-kira budget bulanan yang kamu pikir bisa alokasikan berapa?”

—

Objection 4: “What happens if I never get a critical illness?”

Don't say “That’s actually good news” (dismissive) or “you should hope you never claim”

Do say “That’s actually where this product’s structure becomes an advantage over pure CI products. If you stay healthy throughout the 10-year policy, you receive the guaranteed cash payments in years 6 through 9, and the full maturity benefit at the end — which for Plan 5 is 500% of your annual premium, or roughly equivalent to your total premiums paid back to you. So the product gives you CI protection for 10 years, death protection with 3% annual escalation, and if nothing bad happens, a guaranteed lump sum at the end. You’re not paying for something you ‘never use’ — you use the policy to maturity and collect.”

Jangan bilang “Itu justru bagus dong” (terkesan meremehkan) atau “semoga kamu nggak pernah klaim”

Sebaiknya bilang “Nah, justru di sini struktur produk ini jadi keunggulan dibanding produk CI murni. Kalau kamu sehat selama 10 tahun masa polis, kamu tetap terima Manfaat Tunai Dijamin di tahun ke-6 sampai ke-9, dan Manfaat Akhir Masa Asuransi di akhir polis — yang untuk Plan 5 nilainya 500% dari premi tahunan, kira-kira setara dengan total premi yang sudah kamu bayar. Jadi produk ini kasih perlindungan CI selama 10 tahun, perlindungan jiwa dengan kenaikan 3% per tahun, dan kalau tidak ada kejadian buruk, ada uang tunai bergaransi di akhir. Kamu nggak bayar untuk sesuatu yang ‘nggak pernah dipakai’ — kamu pakai polisnya sampai maturity dan ambil hasilnya.”

—

Objection 5: “Plan 1 single premium of Rp 1 billion is out of reach for me”

Don't say “Then you should consider another product entirely”

Do say “Plan 1 is specifically designed for customers who have a lump sum to deploy — it’s more of an investment alternative than an entry-level protection product. But that’s exactly why there are two other plans. Plan 5 starts at Rp 24 million per year, which is Rp 2 million per month. Plan 10 starts at Rp 12 million per year, which is Rp 1 million per month — or about Rp 3 million per quarter. The minimum sum assured adjusts accordingly. Let’s look at Plan 10 — what sum assured were you thinking would be meaningful for your family’s protection needs?”

Jangan bilang “Kalau begitu mungkin produk lain lebih cocok”

Sebaiknya bilang “Plan 1 memang khusus dirancang untuk nasabah yang punya dana tunai besar untuk ditempatkan — lebih ke alternatif investasi daripada produk proteksi entry-level. Makanya ada dua plan lain. Plan 5 mulai dari Rp 24 juta per tahun, atau sekitar Rp 2 juta per bulan. Plan 10 mulai dari Rp 12 juta per tahun, sekitar Rp 1 juta per bulan — atau Rp 3 juta per kuartal. Uang Pertanggungan minimumnya menyesuaikan. Mari kita lihat Plan 10 — kira-kira berapa Uang Pertanggungan yang menurutmu cukup bermakna untuk perlindungan keluargamu?”

—

1. Early vs Final stage definitions are specific — do not oversimplify. The CI staging has precise medical criteria. “Early stage cancer” under this policy is defined by specific TNM classifications (e.g., T1a/T1b/T1c for prostate, T1N0M0 for thyroid/bladder). Carcinoma-in-situ (CIS) qualifies under early stage under specific conditions. Agents must not promise that “any cancer diagnosis” triggers early-stage payout — the customer’s specific diagnosis must match the clinical definitions in the policy schedule. Mis-stating the CI trigger criteria is a POJK conduct violation and a claims dispute risk.

2. Guaranteed cash value is not guaranteed profit. The Manfaat Tunai Dijamin (guaranteed cash benefit) is a contractually guaranteed periodic payment — but the net return over 10 years from Plan 5 is approximately 8% total, not per annum. Agents must not present this as a high-yield savings product. The guaranteed cash is a structural feature, not an investment return. Comparing it to deposit rates or investment returns without context is misleading and constitutes mis-selling under OJK regulations.

3. The 3% annual escalation applies to the death benefit only — not to CI benefits. The death SA grows 3% per year (capped by entry age band). The CI payout (early stage or final stage) is always based on the original SA at policy inception, not the escalated SA. Agents must not state that “your CI cover also grows 3% per year.” After a terminal illness payout, the death benefit escalation stops permanently.

4. Plan 1 single premium suitability check is mandatory. At Rp 1 billion minimum single premium, Plan 1 involves a substantial capital commitment from a single customer. OJK’s POJK conduct rules require agents to conduct a suitability assessment confirming the customer’s financial capacity, risk tolerance, and understanding that this is an insurance product, not a bank deposit and not guaranteed by LPS (Lembaga Penjamin Simpanan). The brochure explicitly states: “Produk Asuransi Mandiri Secure CritiCare adalah Produk Asuransi dan bukan merupakan tanggung jawab dan produk Bank serta tidak dijamin oleh LPS.” This disclosure must be communicated verbally and in writing to Plan 1 prospects.

5. The waiting period and survival period are non-negotiable claim gates. CI claims require passing a 80-day waiting period from policy commencement and a 14-day survival period from diagnosis. Death claims also require a 30-day waiting period (except accident). Customers who are diagnosed within the waiting period will not receive the CI benefit. Agents must disclose this clearly at point of sale, particularly for customers with known or suspected health issues. Covering up a pre-existing condition at application is grounds for claim rejection.

6. Maturity return multiples can be misread — clarify the denominator. The maturity benefit for Plan 5 is stated as “500% of annual base premium.” This sounds like a 5x return, but the customer paid premiums for 5 years — so total premiums paid is approximately the same as the maturity payout. The “500%” is 500% of one year’s premium, not 500% of total premiums paid. Agents who let customers believe they are receiving 5x their total investment are creating a mis-selling exposure and a post-maturity complaint risk.

7. POJK conduct tightening — bancassurance channel disclosures. AXA Mandiri sells through Bank Mandiri branches via Financial Advisors. The brochure explicitly states that commissions paid to the bank are embedded in the premium. For Legacy Income agents who encounter customers who were previously pitched by AXA Mandiri’s bancassurance channel, be aware that OJK’s tightening conduct rules (POJK No. 8/POJK.05/2023 and related issuances) require clear separation between banking and insurance products. If a customer was confused about whether Secure CritiCare is a deposit product, that is a competitor mis-selling situation that should be documented carefully, not used as a sales tactic without proper handling.

---

---

1. Build a Secure CritiCare vs Allianz Flexi CI comparison sheet for agent training. The most common competitive encounter for Legacy Income agents will be prospects already introduced to Secure CritiCare by a Bank Mandiri branch FA. Prepare a one-page comparison: 4 conditions vs 77 conditions, 10-year term vs lifetime coverage, bancassurance vs independent agent service model. Frame it as a genuine trade-off discussion, not a product-bashing exercise — OJK conduct rules prohibit unfair competitor disparagement. Delivery target: within 14 days.

2. Identify which active prospects may have been pitched Secure CritiCare via bancassurance. If any Legacy Income pipeline prospects bank with Bank Mandiri and are in the 40–55 age range, flag them for proactive outreach. These prospects may have received a Secure CritiCare pitch. The counter-positioning conversation — Allianz Flexi CI’s broader condition coverage, lifetime protection, and independent agent service model — should be delivered before the prospect’s contemplation period closes. Delivery target: within 7 days (pipeline audit).

3. Prepare an “unbundled” alternative proposal for Secure CritiCare’s endowment-CI audience. Secure CritiCare appeals to customers who want CI + guaranteed savings in one product. Legacy Income does not have an identical single-product answer. Prepare a proposal combining Allianz Flexi CI (pure CI, broad conditions) with a separate unit-linked or endowment savings plan, and show the total premium, CI benefit, and savings mechanics side by side. This gives agents a structured rebuttal for customers who say “but Secure CritiCare gives me everything in one product.” Delivery target: within 21 days.

4. Confirm Legacy Income agent understanding of CI staging definitions. Agents must be able to explain early-stage vs final-stage CI payouts clearly — both for Secure CritiCare (to discuss competitively) and for any Allianz CI products in the portfolio. Run a quick internal knowledge check: ask agents to explain the difference between an early-stage CI payout and a final-stage payout in simple language. Common misconception: that “early stage” means “the easy version” with low payout. The correct framing is that early-stage pays 50% SA as a living benefit at diagnosis, with the balance available if disease progresses. Delivery target: within 14 days.

5. Monitor AXA Mandiri for product updates, price changes, or new CI additions. AXA Mandiri is a major bancassurance player backed by Bank Mandiri’s branch network of 1,500+ locations. They are a consistent competitive presence in the Indonesian life insurance market and have won multiple awards including Market Leader Asuransi Jiwa 2024. Product enhancements — particularly if they expand CI condition coverage — could materially shift the competitive landscape. Set a quarterly review flag to check for any RIPLAY or brochure updates to Secure CritiCare. Delivery target: schedule for Q3 2026 review.

---